The documents shared here provide just a small snapshot of information available in these areas. For more information on any of these areas, please contact us.
Market Dynamics
- Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study Dodd P.J., Gardiner E., Coghlan R., Seddon J.A.; Lancet Glob Health 2014; Published Online July 9, 2014 http://dx.doi.org/10.1016/ S2214-109X(14)70245-1 available here
- Understanding Market Size and Reporting Gaps for Paediatric TB in Indonesia, Nigeria and Pakistan: Supporting Improved Treatment of Childhood TB in the Advent of New Medicines; Renia Coghlan, Elizabeth Gardiner, Farhana Amanullah, Chikwe Ihekweazu, Rina Triasih, Malgorzata Grzemska, Charalambos Sismanidis; Research Article | published 13 Oct 2015 | PLOS ONE 10.1371/journal.pone.0138323 available here
- Knowledge and malaria treatment practices using artemisinin combination therapy (ACT) in Malawi: survey of health professionals Kalilani-Phiri L., Lungu D., Coghlan R.; Malaria Journal 2011, Vol 10 p. 279 (access the article)
- Tracking Progress in Scaling-Up Diagnosis and Treatment for Malaria : A Compilation of Data on African Malaria Endemic Countries’ Estimates of their Commodity Needs and Funding Available
Medicines for Malaria Venture, RBM, MSH; Sept 2010 (see the report)
- Supply Chain and Price Components of Antimalarial Medicines: Uganda 2007
Medicines for Malaria Venture, December 2008 (see the report) (pdf, 2.38 MB)
- Understanding the Antimalarials Market : Uganda 2007, An Overview of the Supply Side
Medicines for Malaria Venture, December 2008 (see the report) (pdf, 5.34 MB)
Access to Medicines
- A Risky Business: Saving Money and Improving Global Health through Better Demand Forecasts
Center for Global Development, May 2007 (see the report)
- Understanding more about the anti-malarials market in Africa: progress in a new field of research ASTHM, November 2009
(symposium summary)
(IMS presentation)
(Boston University presentation)
(AMFm presentation)
(Village Reach presentation)
- Understanding the anti-malarials market: do we know enough?
ASTHM, December 2008
- Supply Chain and Price Components of Antimalarial Medicines: Uganda 2007
Medicines for Malaria Venture, December 2008 (see the report) (pdf, 2.38 MB)
- Understanding the Antimalarials Market : Uganda 2007, An Overview of the Supply Side
Medicines for Malaria Venture, December 2008 (see the report) (pdf, 5.34 MB)
- TESS Response to the High Level Panel on Access to Medicines (Feb 2016)
- Ensuring that Developing Countries have Access to New Healthcare Products: The Role of Product Development Partnerships Brooks, A.D., Wells, W.A., McLean, T.D., Khanna, R., Coghlan, R., Mertenskoetter, T., Privor-Dumm, L.A., Krattiger, A., Mahoney, R.T.; Innovation Strategy Today (2010) 3 (1) 1-5 (access the article)
Other Topics
- « About Health: Let’s show we mean business » , IBLF / GAVI Alliance meeting – Malaria Session; Medicines for Malaria Venture, March 2010 (meeting report)
- UN Secretary General’s Report on the Sustainable Development Goals Post-2015-development-agenda (PDF, 1.2 MB)
- The Impact of UK Companies on the Millennium Development Goals : Based on a survey of UN Global Compact UK Network Members
International Business Leaders Forum; London, June 2010 (article on MDG6)